News Archives

SPR^® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT^® PNS System

February 1, 2024

Cleveland, Ohio – February 1, 2024 – SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, …

Category: News

Head-to-toe* pain relief possibilities with SPRINT^® PNS

January 18, 2024

Whether a patient presents with pain in the head and neck, foot and ankle, or any location in between, the goal of treatment is the same — the least invasive approach that will provide safe, effective …

Category: News

SPR^® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024

January 16, 2024

– Data presented features nerve targets throughout the body, highlighting the versatility of the SPRINT® PNS System – Cleveland, Ohio – January 16, 2024 – SPR Therapeutics, Inc. will be …

Category: News

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT^® PNS System for Low Back Pain

December 12, 2023

– RESET is the largest prospective, multicenter randomized controlled trial of SPRINT PNS conducted to date – Cleveland, Ohio – December 12, 2023 – SPR Therapeutics, Inc. today announced the …

Category: News

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SPR^® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT^® PNS System

Head-to-toe* pain relief possibilities with SPRINT^® PNS

SPR^® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT^® PNS System for Low Back Pain

SPR® Therapeutics Named #1 on Crain’s Cleveland Business Fast 50 list

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead